<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20131225015932N15</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-11-23</date_registration>
      <primary_sponsor>Shiraz University of Medical Sciences</primary_sponsor>
      <public_title>Investigation the effect of valgus unloading knee brace on gait harmonic ratio in patients with medial compartment knee osteoarthritis</public_title>
      <acronym></acronym>
      <scientific_title>Investigation the effect of valgus unloading knee brace on gait harmonic ratio in patients with medial compartment knee osteoarthritis</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-11-24</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>20</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/42518</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Subjects will be divided equally between the intervention and control groups according to the randomized block allocation method.
How to allocate randomly by variable block method:
Considering that there are two treatment modalities (Brace A and Control B) in this study, there will be six different conditions considering quadri blocks:
1-AABB 2-BBAA 3-ABAB 4-BABA 5-ABBA 6-BAAB
Then we create random numbers using the computer. For numbers between 0 to 1/6 compound 1, numbers between 1/6 to 2/6 compound 2, numbers between 2/6 to 3/6 compound 3 and ... will be considered, Blinding description: After selecting the samples, one person (x) performs the evaluations on all subjects . After performing the measurements, another person (y) divides the patients into two groups, and then another person (z) applies the interventions to the patients. At the end of the study period (1 month), patients will be referred one week later and the person who performed the measurement (x) will repeat the measurements on all subjects. It is noteworthy that the measurements will be made without brace. So the person making the measurements will not be aware of the nature of the grouping of people.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Knee osteoarthritis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Intervention group wear knee unloading valgus brace for 4 weeks, daily and 4 hours daily while standing and during daily activities and perform exercises which similar to control group. Patients are asked to record hours of use of the brace. Intervention 2: Control group: During the intervention, the control group performs similar exercises to the intervention group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Study participants' personal data will be shared after unidentifiable individuals

When:
The access period begins 6 months after the results are published

To whom:
All academics as well as the public can access this data

Conditions:
The data will be made publicly available for further analysis with a citation

Where to obtain:
Dr. Alireza Motaleh,  Rehabilitation Sciences school, Shiraz University of Medical Sciences, Chamran Boulevard, Abivardi Ave., Phone 00987136271551, Email Motealleh@sums.ac.ir

How to obtain:
6 months after the results are published, people will be notified by email or phone

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Alireza Motealleh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Rehabilitation Sciences school,  Abivardi Ave One , Chamran Boulevard, Shiraz</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>71345-1733</zip>
        <telephone>+98 71 3627 1551</telephone>
        <email>Motealleh@Sums.ac.ir</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Alireza Motealleh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Rehabilitation Sciences school,  Abivardi Ave One , Chamran Boulevard, Shiraz</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1733 -71345</zip>
        <telephone>+98 71 3627 1551</telephone>
        <email>Motealleh@Sums.ac.ir</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Symptomatic unilateral knee osteoarthritis
Knee medial compartment involvement
Age 45-75 years
Ability to walk at least 15 meters without auxiliary equipment
K&amp;L grade ≥2 (based on knee x-ray most related to one last year)
PI-NRS ≥ 2</inclusion_criteria>
      <agemin>45 years</agemin>
      <agemax>75 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Articular  and lower extremity fractures
History of knee and spine and lower extremity surgery in the past 6 months
knee and hip replacement
tibial osteotomy
Any soft, neurological or vascular tissue problems where wearing a brace is harmful for the long term, including varicose veins and skin problems
Obesity enough to make wearing a brace uncomfortable and uneffective (weighing more than 20% of ideal body weight)
Systemic or metabolic diseases including diabetes
Any condition or diseases other than osteoarthritis that affects walking, including stroke and Parkinson's
chronic low back pain
Ligamentous injuries of the lower extremities
Other rheumatologic diseases except knee osteoarthritis</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M17</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Osteoarthritis of knee</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Intervention group wear knee unloading valgus brace for 4 weeks, daily and 4 hours daily while standing and during daily activities and perform exercises which similar to control group. Patients are asked to record hours of use of the brace</i_keyword>
      <i_keyword>Control group: During the intervention, the control group performs similar exercises to the intervention group</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Harmonic ratio measured with accelerometer. Timepoint: Baseline (before intervention) and one week after intervention (one month intervention). Method of measurement: Based on studies to calculate the harmonic gait ratio, accelerometer (Biomethrics) will be fitted to the lower lumbar vertebrae(l4-l5) at the lower back. Gait analysis will be performed using an accelerometer in the laboratory environment as individuals walk a 15-meter-long, horizontal path at their usual speed; a heel  switch will be connected  in the heel area of right foot to define the start of the walking cycle ; the linear acceleration of the trunk will be sampled along the anterior-posterior, medial-lateral, and vertical axes at a frequency of 200 Hz. Signal processing will be performed using matlab software. To calculate the harmonic ratio using fourier transformation, the contents of the in phase accelerated signals (even harmonics) are compared to the contents of out-of-phase signals (odd harmonics).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Pain and disability measered with KOOS quationniare. Timepoint: Baseline (before intervention) and one week after intervention (one month intervention). Method of measurement: KOOS Questionnaire: Knee Injury and Osteoarthritis Outcome Score This questionnaire contains 42 items that assess the patient's opinion on the five dimensions related to the knee and its problems, including: pain (9 questions), other specialized symptoms of illness (7 Questions), daily life performance (17 questions), recreational and sports performance (5 questions), and knee-related quality of life (4 questions).</sec_outcome>
      <sec_outcome>Balance. Timepoint: Baseline (before intervention) and one week after intervention (one month intervention). Method of measurement: Star Equilibrium Test: To do this test, 8 strip strips with a 45 degree angle are attached to the ground. Evaluation will be done with the bare foot, and the patient will be asked to stand in the center of the star with the leg that is stance positioned and center the arch, while maintaining the balance on the leg in the center, and with the other foot touch the longest distance on any tape.</sec_outcome>
      <sec_outcome>Pain meassured with  PI-NRS (Pain intensity numeric range scale). Timepoint: Baseline (before intervention) and one week after intervention (one month intervention). Method of measurement: An 11-point scale that reports the patient's pain level. The patient is asked to choose a number between 0 and 10 that is most proportional to their pain intensity.</sec_outcome>
      <sec_outcome>Isometric strength of quadriceps. Timepoint: Baseline (before intervention) and one week after intervention (one month intervention). Method of measurement: Isometric quadriceps muscle strength will be measured using a handheld dynamometer.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shiraz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-10-09</approval_date>
        <contact_name>Ethics committee of Shiraz University of Medical Sciences</contact_name>
        <contact_address>Rehabilitation school of Shiraz University of Medical Sciences, Abivardi Ave., Chamran Boulevard shiraz Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
